The size of the Global Fluorescence In-Situ Hybridization (FISH) Imaging Systems is estimated to be growing at a CAGR of 8.1% from 2021 to 2026. The size of the market is predicted to be worth USD 1313.7 million by 2026 from USD 890 million in 2021. A FISH imaging system is a type of molecular cytogenetic technique that utilizes fluorescent probes.
Probes are generally derived from the DNA fragments isolated, purified, and amplified for the Human Genome Project. There are a lot of imaging techniques like Single-molecule RNA, Fiber, and Flow MA. FISH is mostly used in clinical studies as well as to compare the genomes of two biological species. FISH is also used in the microbial ecology sector to identify microorganisms.
MARKET DRIVERS:
Y-O-Y growth in the prevalence of cancer and other chronic diseases, growing expenditure on healthcare and increasing financial support for Research and Development in the field of genomics, and rising awareness regarding the advantages of FISH Imaging Systems are expected to drive market growth.
In the diagnosis of diseases caused by bacteria or viruses, FISH imaging systems are gaining prominence. FISH imaging systems' demand is expected to increase as the prevalence of cancers and genetic disorders such as autism, solid tumors, lymphoma, leukemia, and other developmental syndromes increases. FISH is a technique for detecting the presence or absence of complex gene sequences in cells or tissues. In the field of in-vitro diagnostics, technologically innovative devices are still driving the market. For instance, one of the main developments responsible for increased demand for FISH imaging systems is implementing 3D FISH technology. Additionally, increased awareness of the system's related advantages, such as rapid analysis, improved visualization, high accuracy of performance, and a large variety of applications, is one of the main factors driving the market.
Furthermore, emerging markets, technical advances, and the increasing use of illuminators, CCD cameras, microscopes, and fluoroscopy for infectious disease diagnosis are expected to create lucrative growth prospects for the FISH imaging systems market in the coming years. Furthermore, increasing demand for rapid, responsive, and reliable diagnostic techniques for disease confirmation and raising awareness, increased healthcare investment, and robust R&D for the production of novel imaging systems are projected to fuel growth over the forecast period.
MARKET RESTRAINTS:
But, factors like high prices and lengthy processing techniques are hindering the advancement of the market. The lack of funds to build and manage a FISH system is a significant challenge for most countries. The reliability of the FISH system to produce accurate results is also a key challenge for this market.
The high cost of FISH imaging devices, the ambiguous regulatory framework, and the shortage of skilled labor are the market's main major obstacles. For certain uses, reagents and probes were insufficient. New fluorescence dye technology and spin-off research from the Human Genome Project, on the other hand, have had a significant impact. The lack of a high-quality FISH imaging device has harmed the demand for FISH imaging systems. It has also made services for diagnosis in healthcare environments more difficult to navigate.
COVID-19 Impact on the global FISH imaging systems market:
The COVID-19 pandemic has had a huge impact on life and businesses. It has turned into a worldwide pandemic that has afflicted nearly every country globally and destroyed several market functions. In processing plants, R&D centers, and throughout other business divisions, full lockdown and social distancing norms had to be enforced. Supply chains have been negatively impacted by labor shortages, infrastructure, and shipping constraints, resulting in manufacturing losses and revenue declines. During the first half of 2020, the demand for fluorescence in situ hybridization (FISH) imaging systems experienced a similar downturn. Fluorescence in situ hybridization (FISH) is a macromolecule identification technique that exploits DNA/RNA or DNA double strands' complementary nature. COVID-19 has had a positive influence on the market in the fourth quarter of 2020. Autism, solid tumors, lymphoma, leukemia, and other neurological syndromes are all treated by FISH. As a result, FISH is now being used to research the effects of coronavirus in an individual. It's because FISH is simple to use and consistently produces accurate results. The ability to map the virus's internal structure using FISH is used to investigate it in great detail.
COVID-19 has impacted the market positively. FISH is used to treat cancers and genetic diseases, such as autism, solid tumors, lymphoma, leukemia, and other developmental syndromes. Therefore, FISH is also now being used to study the coronavirus and how it impacts our bodies. It is due to the reason that FISH is simple to use and provides stability in results. The facility of genome mapping using FISH is used to study the virus’s detailed internal structure. The scientific laboratories are allotting more funding to this section so that an effective vaccine can be made and distributed as quickly as possible.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Product, Application, End Users, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This research report on the global FISH imaging systems market has been segmented and sub-segmented into the following categories: product, application, end-user, and region.
FISH Imaging Systems Market – By Product:
Based on the product, the Instruments segment held the dominant share in 2019 and is expected to grow with a reasonable growth rate. It is because of greater adoption owing to benefits offered by imaging systems such as microscopes, spectrophotometers, and others. The development of technology is also a significant factor contributing to the growth. The increase in popularity has resulted in inaccessibility to more funds, which has promoted the market sub-segment.
FISH Imaging Systems Market – By Application:
The cancer diagnosis segment is generally divided into Lung Cancer, Breast Cancer, and Others based on the application. It captured the most extensive markets share in 2019 and is expected to grow at a fast rate. The technological advancement in the diagnosis of cancer cells using FISH has driven market growth. The increasing number of cancer cases due to the growing population has also contributed to market growth. A rising number of research initiatives by major players for developing advanced systems is expected to increase the scope for growth.
Genetic disorder diagnosis had the second largest market share in 2019. The primary reasons for growth are easy accessibility of the latest technology devices and reduced FISH imaging test costs. The increasing popularity has also increased awareness among people who are new to technology and are ready to adopt it.
FISH Imaging Systems Market – By End Users:
Based on the end-user, the diagnostic labs segment had the largest market share in 2019 and is expected to grow faster, among others. The increased adaption of FISH imaging technology to detect diseases is driving the market growth. The increased accessibility of diagnostic centers for the general public also contributes to the market, and an increasing number of research initiatives for cell research are expected to fuel growth. These systems' significant benefits, including high speed for conducting assays, have made them one of the key cytogenetic diagnostic procedures.
The academic and Scientific Institutes are expected to grow at a reasonable rate. Increased government initiatives and private funding to explore more possibilities of this technology have contributed to the growth of this segment. Technological advancements such as integration with a lab-on-a-chip microfluidic device are anticipated to propel the growth.
FISH Imaging Systems Market – By Region:
Geographically, North America had the dominant share in the industry in 2019 due to market leaders' presence and the presence of a stellar healthcare system and is expected to grow at a promising growth rate during the forecast period. Major players are collaborating to build new products with better technology. It is the primary reason contributing to the growth of the market. The collaboration has also resulted in more extensive research being done in the field.
Europe had the second largest market share in 2019, mainly due to improved healthcare facilities. The rising government intervention for better healthcare quality is driving the market growth. The funding being allotted for research purposes has also increased, which has propelled the market growth.
The Asia Pacific is the fastest-growing region due to increasing disposable income, growing awareness, and growing adoption rate.
KEY MARKET PARTICIPANTS:
Some of the key players dominating the global FISH imaging systems market profiled in this report are BIOVIEW, West Medica Produktions- und Handels- GmbH, PerkinELmer, Inc., Leica Biosystems Nussloch GmbH, Bio Rad Laboratories, Inc., BioTek Instruments, Inc., GE Healthcare, Thermo Fisher Scientific, Inc., TissueGnostics GmbH and Applied Spectral Imaging.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.3 Microscopes
5.1.4 Automated Cell Analyzers
5.1.5 Consumables
5.1.6 Software
5.1.7 Others
5.1.8 Y-o-Y Growth Analysis, By Product
5.1.9 Market Attractiveness Analysis, By Product
5.1.10 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Cancer Diagnosis
5.2.2.1 Lung Cancer
5.2.2.2 Breast Cancer
5.2.2.3 Others
5.2.3 Genetic Disease Diagnosis
5.2.4 Others
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Diagnostic Labs
5.3.3 Academic and Research Institutes
5.3.4 Others
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 BIOVIEW
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 West Medica Produktions- und Handels- GmbH
8.3 PerkinELmer, Inc
8.4 Leica Biosystems Nussloch GmbH
8.5 Bio Rad Laboratories, Inc.
8.6 BioTek Instruments, Inc.
8.7 GE Healthcare
8.8 Thermo Fisher Scientific, Inc.
8.9 TissueGnostics GmbH
8.10 Applied Spectral Imaging
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
